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ABSTRACT 
 
Introduction: Using beta emitter radionuclide is a useful therapeutic modality in the treatment of skin cancers 
in areas which are difficult to cure by other methods. The aim of this research is to evaluate the tissue response 
to beta rays of 166Ho and determine the feasibility of beta emitting radionuclide for treatment of skin cancers. 
Methods: In this work, we have calculated depth dose distribution of 166Ho using Varskin3 code. The code has 
been run for various input parameters to calculate absorbed depth dose for different shape of source.  
Results: Absorbed depth dose variation has been calculated for166Ho beta emitter, in different shape of sources 
such as slab, spherical, cylindrical and 2-D disk shapes. Comparison of the result for different shape sources has 
been presented.  
Conclusion: The result shows that 2-D disk source induces damage to skin cells more than other shape of 
sources. These computational and Lee et al. experimental results are shown that 166Ho radionuclide treatment is 
very useful for skin cancer therapy. One of advantages of using 166Ho radionuclide is that no adverse effect on 
underlying bone and soft tissue due to the physical characteristics of beta rays, high linear energy transfer or 
rapid depth dose fall off is observed.  
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INTRODUCTION 
 
Skin cancer is the most common malignancy 
in human, and more than 95% of basal cell 
carcinomas, the most common form of skin 
cancer, occur in patients more than 40 years 
of age (1). Due to the increasing life span in 
many countries, the incidence of skin cancer 
has been increased continuously. In spite of 
the malignant nature of this cancer, the 
death rate is not high, because basal cell 
carcinomas are slowly progressive (2). 
Radiation therapy of skin cancer using an 
electron beam (3) X-rays (4) or a neutron 
beam (5) has been reported. Treating skin 
cancer with topical application of a 
radioisotope has also been reported, such as 
using 125I-seeds on a gold plaque (6), also a 
very effective and convenient brachytherapy 
for this application using a 166Ho-patch has 
been reported by Chung el al. (7). 
However; several factors such as total dose, 
fractionation regimens, and field size and 
beam quality affect the treatment outcome. 
In general, a total dose ranging 35-70Gy 
with daily fractionation lying in the 2.0- 
3.5Gy is accounted for the optimal 
therapeutic regimen (8-9). The aim of this 
research is to evaluate the tissue response to 
beta rays of 166Ho and determine the 
effective shape of source for treatment of 
skin cancers. In this work, we have run the 
code to calculate skin absorbed depth dose 
variation from the skin surface. This code 
also contained a volume averaged dose 
model and an offset particle model. The 
volume averaged dose model that we have 
used allowed us to calculate the dose 
averaged over a volume of tissue defined by 
a cylinder with diameter equal to that of the 
dose averaging area and bounded at the top 
and bottom by two selected skin depths. 
This model can be used to calculate the dose 
averaged between two depths in tissue, 
which is useful when characterizing the dose 
measured by a finite volume dosimeter such 
as a thermo luminescent dosimeter (10, 11). 
 
METHODS 
 
Varskin3 computer code calculates skin 
dose due to radioactive skin contamination 
provided by RSICC in USA. To run the 
code in windows XP after installation, user 
can contact the basic information section of 
the code to select radionuclide. When the 
desired geometrical parameters and options 
are selected, the calculation is initiated. The 
calculation time is greatly affected by the 
number of radionuclide used in the 
calculation and the various options that are 
selected. This code calculates doses using a 
compiled FORTRAN program while the 
main program that collects the input data is 
written in visual basic (10, 11). With 
running Varskin3 code for calculating dose, 
the required input parameters contain: 
activity of source, cover thickness, cover 
density, air gap thickness, radiation time and 
different source geometry. We have selected 
the default value of 10 cm2 for skin average 
area and 60 minutes for exposure time. 
166Ho is a beta emitter radioisotope with 
Emax=1.84 MeV and half life 26.9 hr. It also 
emits the following photons: 0.081MeV 
with 5.4% and 1.38 MeV with 0.9% 
intensity per decay. 
 
RESULTS AND DISCUSSION 
 
By running Varskin3 code, we have 
calculated the absorbed depth dose variation 
for 166Ho in different form of sources shape 
as shown in Figure 1. The disk source 
geometry model is simple and need to enter 
its diameter and Varskin3 code calculates 
the area of the disk, vice versa when we 
enter the area of the source; it calculates the 
diameter. Source with spherical geometry is 
the simplest three-dimensional geometry; 
because it requires just the source diameter. 
For cylinder model source, requires 
knowledge is the cylinder diameter and the 
cylinder thickness. This geometry require 
the same amount of time to execute as the 
spherical model but generally offers a more 
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accurate dose calculation. Computational 
result shows the calculated dose is more 
sensitive to the cylinder. The slab source 
geometry requires knowledge of three 
physical dimensions: the x-side length, the 
y-side length, and the thickness. The slab 
source geometry requires two to five times 
more execution time than the cylinder and 
sphere geometries, and the accuracy of the 
calculation is significantly lower. The 
geometry characteristics of different sources 
with 60 minutes irradiation time, and any 
cover or air gap have been presented in 
Table 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representations of the 4 type 
source geometry: (a) Disk, (b) Sphere, (c) Cylinder, 
and (d) Slab. 
 
 
 
Table 1. The geometry characteristics of different 
sources with any cover or air gap and 60 min 
irradiation time. 
Source  
shape Diameter Thickness Other lengths 
Cylindrical 1000 μm 1000 μm --- 
Spherical  1000 μm  ---  --- 
2-D Disk  1000 μm  ---  --- 
Slab  --- 1000 μm X =Y=44 μm
 
The result of the absorbed depth dose 
variation for three different shapes of 166Ho 
are shown in Figure 2, which the default unit 
of measure for activity is 1µCi for all 
sources.  
 
 
 
 
 
 
Figure 2. Absorbed depth dose variation for different 
shapes of 166Ho with activity 1µCi. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The normalized dose rate variation for all 
of the sources. 
 
 
As it can be seen, absorbed depth dose 
variation is like an exponential function 
because of the short range of beta ray. The 
results show dose gradient is high near the 
source but with different behavior for 
different sources shape.  
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Figure 4. Comparison  of the normalized absorbed rate variation against to the depth for 1µCi of 166Ho d with 
the result of Lee et al.  
 
 
Regarding to computational results for the 
same activity, disk source induces more 
dose than others to the skin surface and 
minimum dose is due to the slab source. We 
have presented the normalized dose rate for 
all of the sources in Figure 3. We must 
mention that the absorbed dose rate has been 
normalized to the dose rate in 0 mm depth 
for each source in order to show the effect of 
source geometry on dose rate variation.  
Lee et al. (12) used 166Ho source for curing 
five patients including 4 women and 1 man 
in age range 41-95 yr, as well as several 
animal models with superficial squamous 
cell, basal cell carcinoma and Bowen's 
disease in their experimental research. We 
have compared our results with Lee et al. 
experimental data as shown in Figure 4 with 
a very good agreement. 
  
CONCLUSION 
 
The result shows that 2-D disk source 
induces damage to skin cells more than 
other shape of sources. Our results are in 
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good agreement with the experimental data 
of Lee et al. Our computational study and 
Lee et al. experimental results revealed that 
166Ho radionuclide can be used effectively 
for skin cancer therapy. The advantage of 
166Ho radionuclide is that no adverse effect 
on underlying bone and soft tissue due to the 
physical characteristics of beta rays, high 
linear energy transfer or rapid depth dose 
fall off is seen. Varskin3 code is a very 
useful tool for skin dosimetry, as well as it is 
fast, accurate and user friendly. It can be 
used for dose optimization calculation 
especially in beta source over the human 
skin. 
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